Biosimilars group commends FTC probe into business practices of prescription drug middleman
The US Federal Trade Commission (FTC) announced on June 7 that it will examine pharmacy benefit managers’ role at the center of the US pharmaceutical system.
Archives for June 8, 2022
WuXi Biologics launches drug product facility in China for pre-filled syringes
WuXi Biologics says it has successfully launched the GMP operation of its new drug product facility, DP5, which is located in Wuxi, China.